Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026)
Bausch & Lomb (BLCO) posted Non-Current Assets of $11.0 billion for Q1 2026, little changed on a QoQ basis from $11.0 billion in Q4 2025, and up 2.52% year-over-year from $10.7 billion in Q1 2025.
Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb's Non-Current Assets history runs 6 years deep, the most recent figure standing at $11.0 billion for Q1 2026.
- Quarterly Non-Current Assets rose 2.52% year-over-year to $11.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.0 billion (up 3.36% YoY) and the FY2025 annual result came in at $11.0 billion, up 3.41% from the prior year.
- Non-Current Assets was $11.0 billion for Q1 2026 at Bausch & Lomb, roughly flat from $11.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.0 billion in Q4 2025 and bottomed at $8.8 billion in Q3 2022.
- A 5-year average of $10.1 billion and a median of $10.6 billion in 2023 frame the typical range for Non-Current Assets.
- Peak annual rise in Non-Current Assets reached 20.0% in 2023, while the deepest fall reached 2.21% in 2023.
- Bausch & Lomb's Non-Current Assets stood at $9.0 billion in 2022, then gained by 18.8% to $10.7 billion in 2023, then declined by 0.18% to $10.7 billion in 2024, then gained by 3.41% to $11.0 billion in 2025, then slipped by 0.37% to $11.0 billion in 2026.
- Business Quant data shows BLCO's Non-Current Assets at $11.0 billion in Q1 2026, $11.0 billion in Q4 2025, and $11.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | 11.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00 Bn |
| Dec 31, 2025 | 11.05 Bn |
| Sep 30, 2025 | 10.98 Bn |
| Jun 30, 2025 | 10.99 Bn |
| Mar 31, 2025 | 10.73 Bn |
| Dec 31, 2024 | 10.68 Bn |
| Sep 30, 2024 | 10.69 Bn |
| Jun 30, 2024 | 10.48 Bn |
| Mar 31, 2024 | 10.55 Bn |
| Dec 31, 2023 | 10.70 Bn |
| Sep 30, 2023 | 10.60 Bn |
| Jun 30, 2023 | 9.00 Bn |
| Mar 31, 2023 | 8.99 Bn |
| Dec 31, 2022 | 9.01 Bn |
| Sep 30, 2022 | 8.84 Bn |
| Jun 30, 2022 | 9.00 Bn |
| Mar 31, 2022 | 9.19 Bn |
| Dec 31, 2021 | 9.19 Bn |